Nirsevimab is effective for reducing the burden of respiratory syncytial virus (RSV) in infants in real-world settings.

Division of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Rockville, Maryland 20850, United States ...

This underscores just how serious and enduring the effects of RSV-ARI can be.” “Exacerbations of COPD and asthma were the most common adverse clinical outcomes. These pre-existing conditions ...

This underscores just how serious and enduring the effects of RSV-ARI can be.” “Exacerbations of COPD and asthma were the most common adverse clinical outcomes. These pre-existing conditions ...

The Navaho Nation, the largest U.S. tribal nation, ended its mask mandate Jan. 20, 2023. The order had been in effect across the Navajo reservation, which covers more than 27,000 square miles in ...

A Canadian woman who contracted long COVID says her life has radically changed after experiencing the condition for two years, leading her to apply for voluntary euthanasia. Tracey Thompson, a Toronto ...

The infected cells were examined daily under an inverted phase-contrast microscope (Nikon, Japan). When 70–80% of cultured cells showed cytopathic effect (CPE), the cultures were collected in 2.5% ...